Key Points
- CEO Robert Ball sold 10,175 shares of Shoulder Innovations at an average price of $18.45, generating approximately $187,729. He retains 380,824 shares, with the transaction reducing his position by 2.6%.
- Shoulder Innovations reported quarterly revenue of $17.18 million and an EPS loss of $0.49, missing analysts’ expected loss of $0.46. Analysts expect a full-year EPS loss of approximately $1.90.
- Analyst sentiment remains generally positive, with five Buy ratings and one Sell rating and an average price target of $25.50, despite the stock opening at $18.29 and recently declining 1.3%.
Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) CEO Robert Ball sold 10,175 shares of the stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $18.45, for a total value of $187,728.75. Following the transaction, the chief executive officer owned 380,824 shares in the company, valued at $7,026,202.80. This represents a 2.60% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Shoulder Innovations Stock Down 1.3%
Shoulder Innovations stock opened at $18.29 on Tuesday. The company has a debt-to-equity ratio of 0.12, a current ratio of 10.71 and a quick ratio of 8.92. The stock has a market capitalization of $380.84 million, a PE ratio of -9.53 and a beta of -1.77. The business has a 50 day simple moving average of $21.13 and a 200-day simple moving average of $17.37. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $24.59.
Shoulder Innovations (NYSE:SI - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.46) by ($0.03). Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. The business had revenue of $17.18 million for the quarter. On average, analysts anticipate that Shoulder Innovations, Inc. will post -1.9 EPS for the current fiscal year.
Analyst Ratings Changes
Several research firms have issued reports on SI. Piper Sandler reaffirmed an "overweight" rating and set a $25.00 price objective (up from $19.00) on shares of Shoulder Innovations in a report on Friday, August 7th. BTIG Research upped their price target on shares of Shoulder Innovations from $24.00 to $26.00 and gave the stock a "buy" rating in a research report on Friday, August 7th. Weiss Ratings raised shares of Shoulder Innovations from a "sell (d-)" rating to a "sell (d)" rating in a research note on Monday, August 3rd. Finally, UBS Group lifted their price objective on Shoulder Innovations from $27.00 to $28.00 and gave the stock a "buy" rating in a report on Monday, August 10th. Five analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $25.50.
Get Our Latest Stock Analysis on Shoulder Innovations
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the company. Compass Financial Management LLC purchased a new position in Shoulder Innovations in the 2nd quarter valued at $30,000. Integrated Wealth Concepts LLC purchased a new stake in shares of Shoulder Innovations during the second quarter worth $35,000. California State Teachers Retirement System raised its position in shares of Shoulder Innovations by 412.4% in the second quarter. California State Teachers Retirement System now owns 2,941 shares of the company's stock valued at $60,000 after buying an additional 2,367 shares during the last quarter. Blue Trust Inc. acquired a new stake in shares of Shoulder Innovations in the first quarter valued at about $228,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Shoulder Innovations in the first quarter worth about $252,000.
About Shoulder Innovations
(
Get Free Report)
Shoulder Innovations, Inc is a medical device company focused on developing and commercializing orthopedic products for shoulder replacement surgery. The company's business centers on technologies intended to address conditions such as shoulder arthritis, rotator cuff damage and other causes of shoulder pain and limited mobility.
Its product portfolio includes shoulder arthroplasty systems and related implants, including the InSet glenoid technology and humeral components for anatomic and reverse shoulder replacement procedures.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
